Patient perspectives on the implementation of routinised syphilis screening with HIV viral load testing: Qualitative process evaluation of the Enhanced Syphilis Screening Among HIV-positive Men trial.

Grounded theory HIV care Men’s sexual health Patient process evaluation Qualitative interviews Sexually transmitted infections Syphilis

Journal

BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677

Informations de publication

Date de publication:
30 Jun 2021
Historique:
received: 29 11 2020
accepted: 03 06 2021
entrez: 1 7 2021
pubmed: 2 7 2021
medline: 3 7 2021
Statut: epublish

Résumé

Syphilis infections have been on the rise, affecting men living with HIV in urban centres disproportionately. Since individuals in HIV care undergo routine blood testing, HIV clinics provide practical opportunities to conduct regular and frequent syphilis testing. Following the implementation of a routine syphilis testing intervention in HIV outpatient clinics, we conducted a qualitative process evaluation of patient experiences to measure patient acceptability, barriers to implementation, and facilitators of successful uptake. Upon completion of the trial, which took place at four HIV outpatient clinics in Toronto and Ottawa, Canada, we recruited male patients attending these clinics from November 2017 to April 2018. Interviews were conducted on-site and were audio-recorded and transcribed verbatim. All participants provided written informed consent. Interview data were analyzed using grounded theory, assessing qualitative modulators of effective uptake of routinised syphilis testing. A total of 21 male patients were interviewed. Overall, interviewees found the clinical intervention acceptable, endorsing the practice of routinising syphilis testing alongside regular viral load bloodwork. Some men preferred, based on their self-assessment of syphilis risk, to opt out of testing; we considered this as a potential barrier to uptake of population-wide routinised syphilis testing. Interviewees also identified multiple facilitators of successful uptake, including the de-stigmatising of STI testing as a consequence of the universal nature of routinised testing. Participants recommended a routinised syphilis screening intervention to give patients peace of mind surrounding their sexual health. Participants identified HIV care clinics as comfortable and efficient locations to offer testing. Overall, most men were in support of implementing routinised syphilis testing as part of standard HIV care. From the patient perspective, HIV care clinics are convenient places to be tested for syphilis, and the routine approach was viewed to have a de-stigmatisng effect on syphilis testing. ClinicalTrials.gov NCT02019043; registered December 23, 2013.

Sections du résumé

BACKGROUND BACKGROUND
Syphilis infections have been on the rise, affecting men living with HIV in urban centres disproportionately. Since individuals in HIV care undergo routine blood testing, HIV clinics provide practical opportunities to conduct regular and frequent syphilis testing. Following the implementation of a routine syphilis testing intervention in HIV outpatient clinics, we conducted a qualitative process evaluation of patient experiences to measure patient acceptability, barriers to implementation, and facilitators of successful uptake.
METHODS METHODS
Upon completion of the trial, which took place at four HIV outpatient clinics in Toronto and Ottawa, Canada, we recruited male patients attending these clinics from November 2017 to April 2018. Interviews were conducted on-site and were audio-recorded and transcribed verbatim. All participants provided written informed consent. Interview data were analyzed using grounded theory, assessing qualitative modulators of effective uptake of routinised syphilis testing.
RESULTS RESULTS
A total of 21 male patients were interviewed. Overall, interviewees found the clinical intervention acceptable, endorsing the practice of routinising syphilis testing alongside regular viral load bloodwork. Some men preferred, based on their self-assessment of syphilis risk, to opt out of testing; we considered this as a potential barrier to uptake of population-wide routinised syphilis testing. Interviewees also identified multiple facilitators of successful uptake, including the de-stigmatising of STI testing as a consequence of the universal nature of routinised testing. Participants recommended a routinised syphilis screening intervention to give patients peace of mind surrounding their sexual health. Participants identified HIV care clinics as comfortable and efficient locations to offer testing.
CONCLUSIONS CONCLUSIONS
Overall, most men were in support of implementing routinised syphilis testing as part of standard HIV care. From the patient perspective, HIV care clinics are convenient places to be tested for syphilis, and the routine approach was viewed to have a de-stigmatisng effect on syphilis testing.
TRIAL REGISTRATION BACKGROUND
ClinicalTrials.gov NCT02019043; registered December 23, 2013.

Identifiants

pubmed: 34193138
doi: 10.1186/s12913-021-06602-1
pii: 10.1186/s12913-021-06602-1
pmc: PMC8243864
doi:

Banques de données

ClinicalTrials.gov
['NCT02019043']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

625

Subventions

Organisme : CIHR
ID : Canadian Institutes of Health Research
Pays : Canada
Organisme : Canadian HIV Trials Network, Canadian Institutes of Health Research
ID : Canadian HIV Trials Network, Canadian Institutes of Health Research

Références

Clin Infect Dis. 2020 Aug 22;71(5):1243-1247
pubmed: 31560366
Sex Health. 2011 Jun;8(2):159-70
pubmed: 21592429
BMC Infect Dis. 2011 May 18;11:132
pubmed: 21592342
PLoS One. 2018 Jun 20;13(6):e0199395
pubmed: 29924865
Eur J Gen Pract. 2018 Dec;24(1):9-18
pubmed: 29199486
J Assoc Nurses AIDS Care. 2017 Nov - Dec;28(6):907-922
pubmed: 28830704
Expert Rev Anti Infect Ther. 2018 Apr;16(4):321-331
pubmed: 29489420
Sociol Health Illn. 2010 Jan;32(1):57-73
pubmed: 20415807
Sex Transm Dis. 2016 Feb;43(2 Suppl 1):S28-41
pubmed: 26779685
Implement Sci. 2016 Jan 16;11:8
pubmed: 26772390
JMIR Res Protoc. 2019 Jul 04;8(7):e13801
pubmed: 31274111
BMC Infect Dis. 2013 May 28;13:246
pubmed: 23710699
BMJ Open. 2016 Jul 13;6(7):e011453
pubmed: 27412106
JAMA. 2016 Jun 7;315(21):2321-7
pubmed: 27272583
BMC Infect Dis. 2015 Aug 20;15:356
pubmed: 26289937
Qual Health Res. 2012 Jan;22(1):134-43
pubmed: 21873286
J Adv Nurs. 2015 Jul;71(7):1530-8
pubmed: 25825257
J Acquir Immune Defic Syndr. 2010 Oct;55(2):211-6
pubmed: 20585261
Sex Transm Dis. 2018 Mar;45(3):163-168
pubmed: 29420444
Open Forum Infect Dis. 2018 Apr 28;5(6):ofy096
pubmed: 29977956

Auteurs

Kinnon R MacKinnon (KR)

School of Social Work, York University, 4700 Keele Street, M3J 1P3, Toronto, Ontario, Canada.

Ramandip Grewal (R)

MAP Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, 30 Bond Street, M5B 1W8, Toronto, Ontario, Canada.

Darrell Hs Tan (DH)

MAP Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, 30 Bond Street, M5B 1W8, Toronto, Ontario, Canada.
Department of Medicine, University of Toronto, Toronto, Canada.
Toronto General Research Institute, University Health Network, Toronto, Canada.
Division of Infectious Diseases, St. Michael's Hospital, Unity Health Toronto, Toronto, Canada.

Rodney Rousseau (R)

Department of Immunology, University of Toronto, 1 King's College Cir, M5S 1A8, Toronto, Ontario, Canada.

John Maxwell (J)

AIDS Committee of Toronto, 543 Yonge Street, 4th floor, M4Y 1Y5, Toronto, Ontario, Canada.

Sharon Walmsley (S)

Department of Medicine, University of Toronto, Toronto, Canada.
Toronto General Hospital, University Health Network, 200 Elizabeth Street, M5G 2C4, Toronto, Ontario, Canada.

Paul A MacPherson (PA)

Division of Infectious Diseases, The Ottawa Hospital, 501 Smyth Road, L1H 8L6, Ottawa, Ontario, Canada.
Ottawa Hospital Research Institute, Ottawa, Canada.
Department of Medicine, University of Ottawa, Ottawa, Canada.

Anita Rachlis (A)

Department of Medicine, University of Toronto, Toronto, Canada.
Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, M4N 3M5, Toronto, Ontario, Canada.

Nisha Andany (N)

Department of Medicine, University of Toronto, Toronto, Canada.
Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, M4N 3M5, Toronto, Ontario, Canada.

Sharmistha Mishra (S)

MAP Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, 30 Bond Street, M5B 1W8, Toronto, Ontario, Canada.
Division of Infectious Diseases, Department of Medicine, University of Toronto, Toronto, Canada.
Institute of Medical Science, University of Toronto, Toronto, Canada.
Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Canada.

Vanessa G Allen (VG)

Public Health Ontario Laboratories, Public Health Ontario, 661 University Avenue, M5G 1M1, Toronto, Ontario, Canada.

Ann N Burchell (AN)

MAP Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, 30 Bond Street, M5B 1W8, Toronto, Ontario, Canada. ann.burchell@unityhealth.to.
Department of Family and Community Medicine, St. Michael's Hospital, Unity Health Toronto, 30 Bond Street, M5B 1W8, Toronto, Ontario, Canada. ann.burchell@unityhealth.to.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH